FIELD: technological processes.
SUBSTANCE: invention relates to a method of producing niosomal form of cefatoxime by reversed-phase distillation, comprising: chloroform sorbital monostearate (Span 60) solution, cholesterol, polyethylene glycol-4000 and dicetyl phosphate in molar ratio of 60:34:5:1 respectively (38 mmol of components per 50 ml of chloroform) are mixed with a solution of cefotaxime (3 mg/ml) in 0.01 M phosphate-salt buffer pH 7.4 in ratio of organic and aqueous phases of 5:1, then the mixture is exposed to an ultrasonic disintegrator for 5 minutes, amplitude of 7.5 mcm, frequency of 20 kHz, emulsion is moved into a round bottom flask with a teflon mixer and the chloroform is distilled on a rotary evaporator for 20 minutes at pressure of 0.175 bar, temperature (26±1) °C and 150 rpm, then 25 minutes at pressure of 0.175 bar, temperature (55±1) °C, 200 rpm, then, 20 % of initial volume of aqueous phase is added to mixture and distillation is continued for 45 minutes at pressure of 0.175 bar, temperature (26±1) °C and 140 rpm, the preparation is transferred into clean utensils and left at (20±5) °C for 12 hours.
EFFECT: method provides niosomes with encapsulated cefatoxime with high efficacy of activating substance (63,7 %) and can be used for microencapsulation of antibacterial preparations in niosomes.
1 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING NIOSOMAL FORM OF GENTAMICIN | 2023 |
|
RU2805933C1 |
METHOD OF PRODUCING NIOSOMAL FORM OF OFLOXACIN | 2014 |
|
RU2583135C1 |
METHOD FOR CHEMICAL MODIFICATION OF SURFACE OF MICROCONTAINERS BASED ON MONOSTEARATE SORBITAN OF FLUORESCEIN DERIVATIVES | 2018 |
|
RU2675367C1 |
METHOD FOR DETERMINING THE RELEASE RATE OF CEFOTAXIME ENCAPSULATED IN NIOSOMES IN VITRO | 2020 |
|
RU2754850C1 |
DOXORUBICIN AND ORGANOSILICON NANOPARTICLES-NIOSOMES- BASED PHARMACEUTICAL GEL FOR SKIN CANCER TREATING | 2014 |
|
RU2600164C2 |
PHARMACEUTICAL NIOSOMAL GEL BASED ON N-HYDROXY-2-(2-(NAPHTALENE-2-YL)-1H-INDOLE-3-YL)-2-PHENYLACETAMIDE WITH ANTI-TUMOUR ACTIVITY TO GLIOBLASTOMA | 2015 |
|
RU2627449C2 |
METHOD FOR OBTAINING CHITOSAN NANOPARTICLES WITH INCLUDED CIPROFLOXACIN | 2020 |
|
RU2751699C1 |
TRANSDERMAL ANTHELMINTIC AGENT OF SILICONE NIOSOMES WITH ALBENDAZOLE | 2013 |
|
RU2541156C1 |
METHOD FOR MAKING TRANSDERMAL PATCH CONTAINING PEG-12 DIMETHICONE NIOSOMES | 2012 |
|
RU2539397C2 |
METHOD FOR FRACTIONATION OF NIOSOMES | 2020 |
|
RU2754849C1 |
Authors
Dates
2019-05-14—Published
2018-10-08—Filed